Pre-Operative Computed Tomography Coronary Angiography to Detect Significant Coronary Artery Disease in Patients Referred for Cardiac Valve Surgery

Pre-Operative Computed Tomography Coronary Angiography to Detect Significant Coronary Artery Disease in Patients Referred for Cardiac Valve Surgery Willem B. Meijboom, Nico R. Mollet, Carlos A. G. Van Mieghem, Jolanda Kluin, Annick C. Weustink, Francesca Pugliese, Eleni Vourvouri, Filippo Cademartiri, Ad J. J. C. Bogers, Gabriel P. Krestin, Pim J. de Feyter We assessed the diagnostic performance of the latest 64-slice computed tomography (CT) scanner to rule out or detect significant coronary stenoses in patients referred for cardiac valve surgery. The study population comprised 70 patients. Ninety-two percent (48 of 52) patients with angiographically normal or non-significant coronary angiograms were correctly identified. All patients (18 of 18) with significant coronary artery disease were correctly diagnosed. The 64-slice CT coronary angiography technology accurately rules out the presence of significant coronary stenoses in patients undergoing valve surgery and allows CT coronary angiography implementation as a gatekeeper for invasive conventional coronary angiography. We studied the diagnostic performance of 64-slice computed tomography coronary angiography (CTCA) to rule out or detect significant coronary stenosis in patients referred for valve surgery. Invasive conventional coronary angiography (CCA) is recommended in most patients scheduled for valve surgery. During a 6-month period, 145 patients were prospectively identified from a consecutive patient population scheduled for valve surgery. Thirty-five patients were excluded because of CTCA criteria: irregular heart rhythm (n = 26), impaired renal function (n = 5), and known contrast allergy (n = 4). General exclusion criteria were: hospitalization in community hospital (n = 4), no need for CCA (n = 4), previous coronary artery bypass surgery (n = 1), or percutaneous coronary intervention (n = 4). Of the remaining 97 patients, 27 denied written informed consent. Thus, the study population comprised 70 patients (49 male, 21 female; mean age 63 ± 11 years). Prevalence of significant coronary artery disease, defined as having at least 1 ≥50% stenosis per patient, was 25.7%. Beta-blockers were administered in 71%, and 64% received lorazepam. The mean heart rate dropped from 72.5 ± 12.4 to 59.5 ± 7.5 beats/min. The mean scan time was 12.8 ± 1.3 s. On a per-patient analysis, the sensitivity, specificity, and positive and negative predictive values were: 100% (18 of 18; 95% confidence interval [CI] 78 to